Relationship Between Early Maladaptive Schemas, COVID-19 Anxiety, and Death Anxiety During COVID-19 Pandemic

authors:

avatar Mohammad Davood Mohebi ORCID 1 , * , avatar Jafar Sarani Yaztappeh ORCID 2 , avatar Zahra Nazarali ORCID 3 , avatar Saina Fatollahzadeh ORCID 2 , avatar Behzad Rigi Kooteh ORCID 4

Department of Psychiatry, Zahedan University of Medical Sciences, Zahedan, Iran
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Clinical Psychology, Health Promotion Research Center, Zahedan Branch, Islamic Azad University, Zahedan, Iran
Children and Adolescents Health Research Center, Resistant Tuberculosis Institute, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

how to cite: Mohebi M D, Sarani Yaztappeh J, Nazarali Z, Fatollahzadeh S, Rigi Kooteh B. Relationship Between Early Maladaptive Schemas, COVID-19 Anxiety, and Death Anxiety During COVID-19 Pandemic. Health Scope. 2024;13(1):e138964. https://doi.org/10.5812/healthscope-138964.

Abstract

Background:

The COVID-19 pandemic led to significant concerns and public panic. Due to the ambiguous and deadly nature of this virus, it triggers anxiety related to COVID-19 and a fear of death. On the other hand, early maladaptive schemas (EMSs) can impact anxiety.

Objectives:

The current research aimed to determine the relationship between EMSs, COVID-19 anxiety, and death anxiety during the COVID-19 pandemic among Zahedan University of Medical Sciences (ZAUMS) students in Iran.

Methods:

The present descriptive-analytical cross-sectional study was conducted on 120 ZAUMS students selected through a purposive and convenience sampling technique from May 2022 to December 2022. The data were collected using the COVID-19 Anxiety Scale, the short version of the Young Schema Questionnaire (YSQ), and the Templer Death Anxiety Scale (DAS). The data were analyzed in SPSS 22 using various statistical methods, including frequency analysis, mean calculation, standard deviation calculation, descriptive indices, and multiple regression analysis.

Results:

The disconnection and rejection schema predicted COVID-19 anxiety without a moderator or with a history of contact with a COVID-19 patient as a moderator (B = 0.10, t = 2.69, P < 0.05, R2 = 0.09). Impaired autonomy and performance could predict death anxiety with the moderating role of a history of contact with a COVID-19 patient (B = 0.31 t = 2.14, P < 0.05), history of contracting COVID-19 (B = 0.24; t = 2.12, P < 0.05), discipline, and study period or without any moderator. Over-vigilance could predict death anxiety with the moderating role of discipline or without a moderator (B = 0.41, t = 2.93, P < 0.05).

Conclusions:

Disconnection and rejection with or without a moderator predict COVID-19 anxiety. Over-vigilance, impaired autonomy, and performance schema domain predict death anxiety. Effective moderators in predicting variables are contact with a COVID-19 patient, history of contracting COVID-19, discipline, and study period.

1. Background

According to the World Health Organization, approximately 732.9 million COVID-19 cases and 6.7 million COVID-19-related deaths were reported worldwide from the start of the pandemic until the end of 2022, with the largest global peak in COVID-19 transmission in December 2022. More than three years into the pandemic, countries worldwide continue to face many challenges in responding to the evolving and recurring challenges of COVID-19 while maintaining other Essential Health Services (EHS) (1). As of 2021, there are more than 257 million confirmed cases of COVID-19 worldwide and more than 6 million in Iran (2).

COVID-19 is characterized by death anxiety, which is among the psychological problems caused by this viral infection (3). Death anxiety is defined as an irrational, intense fear of death, recognized as the terror of death or having apprehensive thoughts about death or the events that ensue (4). Several factors contribute to the development, persistence, and responses to death anxiety, the most important of which include innate personality tendencies such as Early Maladaptive Schemas (EMSs) (5). Cognitive schemas are mental structures formed in the individual's psyche and personality from birth. The individual's relationships and responses to different events and phenomena are rooted in these structures (6). People's responses to health anxiety and death anxiety seem to mostly arise from their EMSs (5, 7). Further, the researchers observed that individuals with high levels of COVID-19 fear and anxiety were at a higher risk of psychiatric disorders (8).

Faustino et al.'s (9) study showed that early maladaptive schemas are related to COVID-19 anxiety and mental health. Another study by Silva et al. (10) aimed to assess the correlation between COVID-19 anxiety, death-related concerns, and their effects on psychological well-being. The results indicated that individual differences in the fear of death were associated with their psychological well-being and its correlation with disease anxiety due to COVID-19. On the other hand, bringing the idea of death to prominence through manipulated news did not affect this correlation (10).

Compared to other students, clinical medical students, as a whole, are in closer contact with COVID-19 patients in health centers (11). Therefore, they are more susceptible to disease anxiety and death anxiety, which can largely influence their educational performance and mental health.

The present study aimed to determine COVID-19 anxiety among university students and its correlation with death anxiety and EMSs. The researchers intended to provide a comprehensive overview of disease anxiety, death anxiety, and the frequency of EMSs in students and precisely analyze the correlations between these parameters. Our findings can be used to elucidate effective solutions to manage COVID-19 anxiety in social groups (especially among university students), prevent a decline in students' academic performance, and improve their quality of life.

Previous studies in this field, especially during the COVID-19 pandemic, have documented that anxiety related to COVID-19 may be associated with EMSs and death anxiety; however, these findings cannot be generalized as only a limited number of studies have explored different manifestations of COVID-19 anxiety. Accordingly, further investigations are required to clarify how EMSs are associated with death anxiety in nursing or medical students, which schemas correlate strongly with COVID-19 anxiety, and how some demographic variables affect the severity of COVID-19 anxiety. More studies are also needed to confirm the previous evidence and reach an agreement in this regard.

2. Objectives

The current research aimed to determine the relationship between EMSs, COVID-19 anxiety, and death anxiety during the COVID-19 pandemic among Zahedan University of Medical Sciences (ZAUMS) students in Iran.

3. Methods

3.1. Study Subjects

The present descriptive-analytical cross-sectional study recruited a sample of ZAUMS students in 2022. Based on G*power, the software, we selected 120 ZAUMS students as the research sample using purposive and convenience sampling (Effect size f2 = 0.20, α err proB = 0.05, Power (1-β err prob) = 0.95, Total sample size = 117, Actual power = 0.9511212) (Figure 1).

F tests, linear multiple regression: Fixed model (R2 deviation from zero number of predictors = 7; α err prob = 0.05; effect size f2 = 0.2)
F tests, linear multiple regression: Fixed model (R2 deviation from zero number of predictors = 7; α err prob = 0.05; effect size f2 = 0.2)

The participants responded to a questionnaire to collect data, and convenience sampling was also used to select the sample population. The inclusion criteria were 18 - 45 years old, studying nursing or medicine at the ZAUMS, and informed consent to participate in the study. The exclusion criteria were suffering from a mental disability, having symptoms of psychosis, and suffering from a disease inhibiting cooperation in the study.

3.2. Data Collection Tools

Data collection was performed using standardized questionnaires for the Iranian population. The participants first completed a demographic questionnaire regarding age, gender, history of COVID-19 contraction, contact with a COVID-19 patient, discipline, place of residence, and participation in educational courses.

3.2.1. COVID-19 Anxiety Scale

This 18-item scale was used to assess the level of COVID-19 anxiety. The COVID-19 Anxiety Scale was developed and validated to measure COVID-19-related anxiety in Iran. The items of this scale are scored based on a four-point Likert scale (Never=0, Sometimes=1, Very Often=2, and Always=3). Construct validity showed a moderately negative correlation (Pearson's r = −0.417) with self-rated mental health (12). In this study, the reliability of this test is reported as 0.87 using Cronbach's alpha method.

3.2.2. Templer Death Anxiety Scale

This scale was developed by Templer in 1970 to measure the level of death anxiety. The Templer Templer Death Anxiety Scale (DAS) is a simplified tool widely applied in research studies. It is a self-report questionnaire consisting of 15 true/false questions. Tavakoli and Ahmadzadeh showed that this scale has appropriate validity (13). In this study, the reliability of this test is reported as 0.76 using Cronbach's alpha method.

3.2.3. Young Schema Questionnaire (YSQ)

This scale assesses 15 EMSs. Each schema is measured by answering related questions among 75 questions. The scale items are scored based on a six-point Likert scale ranging between Completely False (=1) and Completely True (=6). Fata and Fata et al. showed that this scale has appropriate validity (14). In this study, the reliability of this test is reported as 0.82 using Cronbach's alpha method.

3.3. Ethical Considerations

The research objectives were clearly explained to the participants. They signed informed consent forms.

The study was registered with the Research Ethics Committee of ZAUMS in Iran with the code IR.ZAUMS.REC.1401.086).

3.4. Study Procedure

After obtaining the required permit from the Vice-Chancellor of Research and the ethics code from the Ethics Committee of ZAUMS, the participants were selected from the students of ZAUMS by convenience sampling. Convenience sampling was done in such a way that there were medical and nursing students studying at ZAUMS, and after reading the invitation letter from the medical school to participate in the research, they called the number on the poster.

They were medical and nursing students studying at ZAUMS who contacted the number on the poster after reading an invitation to the medical school to participate in the research. Then, the participants completed questionnaires distributed by a clinical psychologist with a master's degree from the same university. This was done individually with the researcher in a quiet room. The researcher explained the objectives and procedures of the research to the participants. After obtaining informed consent from the participants, the questionnaires were distributed to them. Notably, the participants were assured that their information would be kept confidential. There was no time constraint for completing the questionnaires.

3.5. Data Analysis

Data analysis was performed in SPSS version 22 using descriptive statistics (mean, standard deviation, frequency, and percentage) and inferential statistics (Pearson's correlation coefficient and multiple regression analysis).

4. Results

The mean age of the participants was 23.71. The research sample included 120 ZAUMS students (39.3% men). We found that 69.3% of the participants were infected with the virus. Also, 34.3% had a history of COVID-19. The field of study for 54.3% of the participants was medicine, while 45.7% were nursing students. The participants' courses were as follows: 64.3% were stagers, 23.6% were interns, and 12.1% were in other courses.

The descriptive results were as follows: COVID-19 anxiety (M = 90.27, SD = 92.6), death anxiety (M = 65.69, SD = 20.75), disconnection and rejection schema domain (M = 47.20, SD = 17.68), impaired autonomy and performance (M = 31.93, SD = 11.30), impaired limits (M = 26.24, SD = 9.45), other-directedness (M = 24.37, SD = 8.05), and over vigilance and inhibition (M = 28.27, SD = 11.49). The results indicated that the skewness value was within the range of ±1.96, and the data were adequately normal.

Evaluation of the beta coefficients showed that the standard coefficients were significant for the EMSs without the moderating role (B = 0.09, t = 1.99, P < 0.05, R2 = 0.09) or with the moderating role of a history of contact with a COVID-19 patient (B = 0.10, t = 2.69, P < 0.05, R2 = 0.09) only in the case of the social disconnection and rejection schema. Therefore, this component can be a reliable predictor of coronavirus anxiety (Table 1).

Table 1.

Results of Multiple Regression Analysis Regarding the Correlation Between EMSs and COVID-19 Anxiety

PredictorBStd. EβTP-Value95% Interval Confidence for B
Lower BoundUpper Bound
Disconnectionand Rejection
Without a moderator0.090.050.2521.9910.04
(Constant)21.0927.615
Disconnectionand rejection0.010.14
History of contact with a COVID-19 patient as a moderator0.100.030.482.6990.008
(Constant)22.71727.553
Disconnectionand rejection0.010.08

The beta coefficients were also significant for the components of impaired autonomy and performance (B = 0.31, t = 2.17, r < 0.05), indicating that this schema can reliably predict death anxiety with the moderating role of the study period in university students (R2 = 0.06). The significant beta coefficient for impaired autonomy and performance showed that with the moderating role of a history of contracting COVID-19 (B = 0.24 t = 2.12, r < 0.05), this schema can also reliably predict death anxiety (R2 = 0.10). The significant beta coefficient for impaired autonomy and performance showed that with the moderating role of a history of contracting COVID-19 patients (B = 0.31; t = 2.14, P < 0.05), this schema can also reliably predict death anxiety (R2 = 0.09) (Table 2).

Table 2.

Results of Multiple Regression Analysis Regarding the Correlation Between EMSs and Death Anxiety

Predictor bStd. EβtP-Value95/0% Interval Confidence for B
Lower BoundLower Bound
Impaired Autonomy and Performance
Without a moderator0.560.200.302.6810.008
(Constant)21.73828.654
Impaired autonomy and performance-0.010.187
History of contact with a COVID-19 patient as a moderator0.310.140.342.1420.034
(Constant)23.60328.517
Impaired autonomy and performance-0.0080.096
History of contracting COVID-19 as a moderator0.240.110.322.1240.03
(Constant)24.1229.26
Impaired autonomy and performance-0.020.06
Discipline as a moderator0.310.140.322.2020.029
(Constant)22.3327.71
Impaired autonomy and performance0.010.11
Study period as a moderator0.310.140.422.1790.03
(Constant)25.2029.75
Impaired autonomy and performance-0.030.05
Over-vigilance
Without a moderator0.420.210.230.0140.04
(Constant)23.9629.96
Over-vigilance-0.060.13
Discipline as a moderator0.410.130.422.9360.004
(Constant)23.6228.45
Over-vigilance-0.0060.10

5. Discussion

EMSs, specifically the disconnection and rejection schema, can predict COVID-19 anxiety only with the moderating role of contact history with a COVID-19 patient or without any moderators. On the other hand, EMSs, specifically the domains of over-vigilance and impaired autonomy and performance, can predict death anxiety. Additionally, the impaired autonomy and performance schema domain can predict death anxiety by considering the moderating role of the field of study, contact history with a COVID-19 patient, history of infection with COVID-19, and training course. Similarly, the domain of over-vigilance schema can predict death anxiety by considering the moderating role of the field of study. Our findings are consistent with previous studies from Portugal (9) and Poland (15). A previous study showed that home quarantine during the COVID-19 pandemic can activate the abandonment schema. It should be noted that this schema plays a role in creating anxiety (16). Therefore, it can be concluded that by controlling the moderating role of contact history with a COVID-19 patient, or in other words, in quarantine conditions where there is no contact with a COVID-19 patient, this schema can predict COVID-19 anxiety. One schema of disconnection and rejection schema domain is mistrust/abuse. A prior study showed that mistrustfulness relates to COVID-19 anxiety. This finding confirms our results about the predicting role of disconnection and rejection schema domain. Also, disconnection schemas can lead people to isolate themselves more, avoiding social interactions and support networks. This isolation can amplify feelings of loneliness and fear, making it harder to cope with the anxiety associated with the pandemic.

Neta et al. demonstrated that in situations characterized by ambiguity, such as the Threat of Shock (TOS), both cognitive and affective functions are impacted, leading to increased vigilance (17). On the other hand, research displayed that tolerance of ambiguity can predict death anxiety (18). We suppose that during the COVID-19 pandemic, individuals' over-vigilance schema domain is activated, so when they confront dangerous ambiguous situations, such as an infected environment, it evokes their death anxiety.

One of the over-vigilance schema domains is negativity/pessimism. The studies showed that pessimism is negatively associated with death anxiety (19). This finding aligns with our results about the predicting role of the over-vigilance schema domain.

Another study found a negative relationship between behavioral inhibition and the over-vigilance schema domain. On the other hand, behavioral inhibition is a mediator in the relationship between fear of COVID-19 and death anxiety (20). Therefore, we can conclude that the over-vigilance schema domain is related to death anxiety through behavioral inhibition.

5.1. Limitations

Purposive and convenience sampling could have affected the reliability of our research. Also, our sample size was small. Relying on the self-report questionnaire was another limitation of our study. This study has some strengths. It addresses a relevant and timely topic related to the COVID-19 pandemic, which was a major global concern during the study period. The use of multiple regression analysis allows for a deeper exploration of the relationships between variables, providing a more nuanced understanding of the factors influencing coronavirus anxiety and death anxiety.

5.2. Conclusions

Our results showed that the disconnection and rejection schema predicts COVID-19 anxiety (B = 0.25, t = 1.99, P < 0.05). Also, over-vigilance (B = 0.23, t = 2.01, P < 0.05) and impaired autonomy and performance schema domain (B = 0.30, t = 2.68, P < 0.001) predicted death anxiety. Disconnection and rejection schema domain could predict COVID-19 anxiety only with the moderating role of contact history with a COVID-19 patient. Our findings on death anxiety differ from the previous study because of the COVID-19 pandemic. These new results may help examine the effects of the COVID-19 pandemic on death anxiety and contribute to meta-theoretical conceptualization and clinical decision-making. From a clinical perspective, assessing EMSs may be especially relevant when psychological factors related to anxiety are identified. In order to apply these findings into clinical practice, further replications and expansion of the results are, however, needed. Future research in this area could consider Longitudinal Studies, Diverse Populations, Mental Health Interventions, and Resilience Factors.

References

  • 1.

    World Health Organization. Fourth round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic: November 2022–January 2023. World Health Organization; 2023.

  • 2.

    Darrudi A, Akbari Sari A, Yunesian M, Daroudi R. Public Attitudes Towards COVID-19 Vaccination: A Cross-Sectional Study in Iran. Health Scope. 2023;12(3). https://doi.org/10.5812/jhealthscope-134323.

  • 3.

    Menzies RE, Menzies RG. Death anxiety in the time of COVID-19: theoretical explanations and clinical implications. Cogn Behav Therap. 2020;13. e19. [PubMed ID: 34191938]. [PubMed Central ID: PMC7308596]. https://doi.org/10.1017/S1754470X20000215.

  • 4.

    Rice J. The relationship between humor and death anxiety. Missouri Western State University. 2009.

  • 5.

    Masoodi S, Hatami HR, Modaress M, Banijamali S. [The mediating role of early maladaptive schemas in relationship between attachment styles and anxiety of death among cancer patients]. Thought Behav Clin Psychol. 2016;11(39):37-46. Persian.

  • 6.

    Young JE, Klosko JS, Weishaar ME. Schema therapy: A practitioner's guide. Guilford Press; 2006.

  • 7.

    Jafari F, Kakawand A, Hakami M. The relationship between early maladaptive schemas and death anxiety and referential thinking. Eur Online J Nat Soc Sci. 2016;4(1 (s)):pp. 2162-71.

  • 8.

    Sahu DP, Pradhan SK, Sahoo DP, Patra S, Singh AK, Patro BK. Fear and anxiety among COVID-19 Screening Clinic Beneficiaries of a tertiary care hospital of Eastern India. Asian J Psychiatr. 2021;57:102543. [PubMed ID: 33517132]. [PubMed Central ID: PMC7836328]. https://doi.org/10.1016/j.ajp.2020.102543.

  • 9.

    Faustino B, Vasco AB, Delgado J, Farinha-Fernandes A, Guerreiro JC. Early maladaptive schemas and COVID-19 anxiety: The mediational role of mistrustfulness and vulnerability to harm and illness. Clin Psychol Psychother. 2022;29(4):1297-308. [PubMed ID: 34989057]. [PubMed Central ID: PMC9015275]. https://doi.org/10.1002/cpp.2706.

  • 10.

    Silva WAD, Brito TRS, Pereira CR. Anxiety associated with COVID-19 and concerns about death: Impacts on psychological well-being. Pers Individ Dif. 2021;176:110772. [PubMed ID: 33612907]. [PubMed Central ID: PMC7879129]. https://doi.org/10.1016/j.paid.2021.110772.

  • 11.

    Bani Hani A, Alaridah N, Abu Abeeleh M, Shatarat A, Rayyan R, Kamal A, et al. Medical students and risk of COVID-19 infection: A descriptive cross-sectional study from the University of Jordan. Ann Med Surg (Lond). 2021;70:102775. [PubMed ID: 34545306]. [PubMed Central ID: PMC8444353]. https://doi.org/10.1016/j.amsu.2021.102775.

  • 12.

    Chandu VC, Pachava S, Vadapalli V, Marella Y. Development and Initial Validation of the COVID-19 Anxiety Scale. Indian J Public Health. 2020;64(Supplement):S201-4. [PubMed ID: 32496255]. https://doi.org/10.4103/ijph.IJPH_492_20.

  • 13.

    Tavakoli MA, Ahmadzadeh B. Investigation of validity and reliability of templer death anxiety Scale. Thought Behav Clin Psychol. 2011;6(21).

  • 14.

    Fata L, Mootabi F, Dobson K, Moludi R, Zeaee K. [Psychometric Properties of Young Schema Questionnaire in an Iranian Non-clinical Sample]. J Mod Psychol Res. 2010;4(16):227-46. Persian.

  • 15.

    Slysz A, Urbanska J. Psychological consequences of experiencing the COVID-19 coronavirus pandemic: early maladaptive schemas and mental health and quality of life. Psychol Health Med. 2023;28(9):2660-71. [PubMed ID: 36799473]. https://doi.org/10.1080/13548506.2023.2179645.

  • 16.

    Fathi K, Shirmardi S, Mahar Z, Koraei A. [Predicting Corona disease anxiety based on maladaptive schemas of abandonment, vulnerability to harm and disease, and perceived social support]. Razi J Med Sci. 2021;28(7):16-25. Persian.

  • 17.

    Neta M, Cantelon J, Haga Z, Mahoney CR, Taylor HA, Davis FC. The impact of uncertain threat on affective bias: Individual differences in response to ambiguity. Emotion. 2017;17(8):1137-43. [PubMed ID: 28910121]. https://doi.org/10.1037/emo0000349.

  • 18.

    Zamani S, Zolfaghari M. The Relationship Between Mindfulness and Tolerance of Ambiguity with Death Anxiety and Improving Sleep Quality in the Elderly. Aging Psychol. 2022;8(3):299-310.

  • 19.

    Barnett MD, Anderson EA, Marsden A3. Is death anxiety more closely linked with optimism or pessimism among older adults? Arch Gerontol Geriatr. 2018;77:169-73. [PubMed ID: 29783138]. https://doi.org/10.1016/j.archger.2018.05.003.

  • 20.

    Khosravani V, Seidisarouei M, Alvani A. Early maladaptive schemas, behavioral inhibition system, behavioral approach system, and defense styles in natural drug abusers. Polish Annal Med. 2016;23(1):6-14. https://doi.org/10.1016/j.poamed.2015.12.003.